These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11136367)

  • 21. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Vakhapova V; Auriel E; Karni A
    Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary report on the treatment of spasticity with 45 per cent ethyl alcohol injections into the muscles.
    Cockin J; Hamilton EA; Nichols PJ; Price DA
    Br J Clin Pract; 1971 Feb; 25(2):73-5. PubMed ID: 5551572
    [No Abstract]   [Full Text] [Related]  

  • 23. Dorsal Longitudinal T-Myelotomy (Bischof II Technique): A Useful, Antiquated Procedure for the Treatment of Intractable Spastic Paraplegia.
    Sitthinamsuwan B; Khampalikit I; Phonwijit L; Nitising A; Nunta-Aree S; Suksompong S
    World Neurosurg; 2018 Aug; 116():e476-e484. PubMed ID: 29753900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis.
    Brar SP; Smith MB; Nelson LM; Franklin GM; Cobble ND
    Arch Phys Med Rehabil; 1991 Mar; 72(3):186-9. PubMed ID: 1998451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial.
    Cutter NC; Scott DD; Johnson JC; Whiteneck G
    Arch Phys Med Rehabil; 2000 Feb; 81(2):164-9. PubMed ID: 10668769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
    Marinelli L; Mori L; Canneva S; Colombano F; Currà A; Fattapposta F; Bandini F; Capello E; Abbruzzese G; Trompetto C
    Int Clin Psychopharmacol; 2016 Jul; 31(4):232-9. PubMed ID: 27003093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Painful muscle spasm reversed by magnesium sulphate. A case report.
    Clinton CW; Braude BM; James MF
    S Afr Med J; 1985 Aug; 68(5):332-3. PubMed ID: 4035497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
    Ungerleider JT; Andyrsiak T; Fairbanks L; Ellison GW; Myers LW
    Adv Alcohol Subst Abuse; 1987; 7(1):39-50. PubMed ID: 2831701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal myelotomy in the treatment of spasticity of the legs.
    Laitinen L; Singounas E
    J Neurosurg; 1971 Nov; 35(5):536-40. PubMed ID: 5120003
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Horne ML
    JAMA; 1976 Jan; 235(3):251. PubMed ID: 946040
    [No Abstract]   [Full Text] [Related]  

  • 32. Lioresal (baclofen) treatment of spasticity in multiple sclerosis.
    Basmajian JV
    Am J Phys Med; 1975 Aug; 54(4):175-7. PubMed ID: 1098477
    [No Abstract]   [Full Text] [Related]  

  • 33. Intrathecal baclofen for spasticity of spinal origin: seven years of experience.
    Penn RD
    J Neurosurg; 1992 Aug; 77(2):236-40. PubMed ID: 1625011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe selective magnesium malabsorption: tests of tolerance of oral magnesium supplements.
    Mettey R; Guillard O; Merle P; Maillet-Picker F
    Magnes Res; 1990 Dec; 3(4):291-5. PubMed ID: 2132677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT; Lee RH; Spehlmann R
    Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Tolosa ES; Soll RW; Loewenson RB
    JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254
    [No Abstract]   [Full Text] [Related]  

  • 37. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.
    Solaro C; Lunardi GL; Capello E; Inglese M; Messmer Uccelli M; Uccelli A; Mancardi GL
    Neurology; 1998 Aug; 51(2):609-11. PubMed ID: 9710049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis.
    Picelli A; Vallies G; Chemello E; Castellazzi P; Brugnera A; Gandolfi M; Baricich A; Cisari C; Santamato A; Saltuari L; Waldner A; Smania N
    J Neurol Sci; 2017 Sep; 380():132-136. PubMed ID: 28870553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonazepam, baclofen and placebo in the treatment of spasticity.
    Cendrowski W; Sobczyk W
    Eur Neurol; 1977; 16(1-6):257-62. PubMed ID: 354938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myotonic-like syndrome in multiple sclerosis.
    Weintraub MI; Megahed MS; Smith BH
    N Y State J Med; 1970 Mar; 70(5):677-9. PubMed ID: 5263956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.